Phase III Randomized Study of Oral Acyclovir in Infants With Herpes Simplex Virus Infection Involving the Central Nervous System

Recruiting

Phase 3

Phase III Randomized Study of Oral Acyclovir in Infants With Herpes Simplex Virus Infection Involving the Central Nervous System

Sponsor:

National Center for Research Resources (NCRR)

Code:

NCT00006132

Conditions

Herpes Simplex

Eligibility Criteria

Sex: All

Age: 0 - 28

Healthy Volunteers: Not accepted

Interventions

acyclovir

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information